| Alpelisib-Induced Diabetic Ketoacidosis in a Non-diabetic Patient T Fugere, AM Roy, I Makhoul Cureus 13 (11), 2021 | 11 | 2021 |
| Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity T Fugere, A Baltz, A Mukherjee, M Gaddam, A Varma, M Veeraputhiran, ... Cancers 15 (21), 5149, 2023 | 10 | 2023 |
| Scurvy in the modern world: Extinct or not? FNU Amisha, SN Ghanta, A Kumar, T Fugere, P Malik, S Kakadia, ... Cureus 14 (2), 2022 | 9 | 2022 |
| Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study F Amisha, P Malik, M Konda, S Kakadia, T Fugere, A Mukherjee Blood 138 (Supplement 1), 4537-4537, 2021 | 4 | 2021 |
| Chryseobacterium gleum Causing Healthcare-Associated Pneumonia in an Adult Male With Diffuse Large B Cell Lymphoma FNU Amisha, T Fugere, J Caceres, JCR Crescencio, N Falls Cureus 13 (11), 2021 | 4 | 2021 |
| Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes F Amisha, M Konda, P Malik, T Fugere, AM Roy, A Mukherjee Blood 138, 1629, 2021 | 2 | 2021 |
| Practical Vitamin D Supplementation Using Machine Learning T Fugere, ZJ Chen, I Makhoul Journal of bone metabolism 27 (2), 111, 2020 | 2 | 2020 |
| S2717 An Owl-Eyed Perspective: CMV Viremia as a Cause of Critical Illness, Pancreatitis, and Marrow Granulomas in an Immunocompetent Patient GA Nageswaran, TP Gandhi, K Moreaux, T Fugere, VK Nagesh, ... Official journal of the American College of Gastroenterology| ACG 119 (10S …, 2024 | | 2024 |
| Nodal metastasis as an immune indicator in cancer (ca) therapy B Fugere, J Chen, TC Fugere, F Mazahreh, N Thalambadu, AM Safar Cancer Research 84 (6_Supplement), 3856-3856, 2024 | | 2024 |
| Honing in on the metastasis machinery JZ Chen, TC Fugere, F Mazahreh, B Fugere, E Delgiacco, AMM Safar Cancer Research 84 (6_Supplement), 1567-1567, 2024 | | 2024 |
| Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms T Fugere, B Fugere, F Amisha, JZ Chen, A Mukherjee, M Gaddam, ... Blood 142, 5346, 2023 | | 2023 |
| Leveraging Deep Neural Networks to Predict Time to Event in Pediatric B-Lymphoblastic Leukemia JZ Chen, A Baltz, T Fugere, EN Sanders, F Amisha, CGG Sanchez, ... Blood 142, 4355, 2023 | | 2023 |
| Participation in a multidisciplinary institutional committee,“RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows. T Fugere, JZ Chen, A Baltz, T Schmit, R Douli, MS Hoque, M Khalil, ... Journal of Clinical Oncology 41 (16_suppl), e18733-e18733, 2023 | | 2023 |
| Weight loss (WL) as a predictive factor for immune oncology (IO). B Fugere, JZ Chen, F Mazahreh, T Fugere, L Mazahreh, AM Safar Journal of Clinical Oncology 41 (16_suppl), e14528-e14528, 2023 | | 2023 |
| 1296. Customized Learning About Bettering Sterile Insertion (CLABSI): A Look at Reducing Hospital Acquired Line Infections L Abusalem, J Smith, T Fugere, Z Tilley, T Savenka, CL Wright, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1127, 2022 | | 2022 |
| Classic hairy cell leukemia with an aggressive presentation T Fugere, S Harley, A Godbole Baylor University Medical Center Proceedings 34 (6), 721-723, 2021 | | 2021 |
| Monitoring C-reactive protein facilitates early discontinuation of immune oncology without compromising outcomes in stage IV non-small cell lung cancer. T Fugere, P Spradley, AM Safar Journal of Clinical Oncology 39 (15_suppl), e21107-e21107, 2021 | | 2021 |
| Expression profile of micro-RNA of lymphovascular invasive colon cancer. Z Chen, T Fugere, Y Pandey Journal of Clinical Oncology 38 (15_suppl), e16109-e16109, 2020 | | 2020 |
| Gender variation in clinical activity and Medicare payments among medical oncologists and hematologists. M Konda, A Roy, R Parikh, T Fugere, M Gullapalli, Y Pandey, R Verma Journal of Clinical Oncology 38 (15_suppl), 11014-11014, 2020 | | 2020 |
